LT3675816T - Pailginto atpalaidavimo anestetinės kompozicijos ir jų gamybos būdai - Google Patents

Pailginto atpalaidavimo anestetinės kompozicijos ir jų gamybos būdai

Info

Publication number
LT3675816T
LT3675816T LTEPPCT/US2018/048329T LTUS2018048329T LT3675816T LT 3675816 T LT3675816 T LT 3675816T LT US2018048329 T LTUS2018048329 T LT US2018048329T LT 3675816 T LT3675816 T LT 3675816T
Authority
LT
Lithuania
Prior art keywords
sustained
preparation
methods
anesthetic compositions
release anesthetic
Prior art date
Application number
LTEPPCT/US2018/048329T
Other languages
English (en)
Inventor
Keelung Hong
Hao-Wen Kao
Yi-Yu Lin
Luke Guo
Original Assignee
Tlc Biopharmaceuticals, Inc.
Taiwan Liposome Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals, Inc., Taiwan Liposome Company, Ltd. filed Critical Tlc Biopharmaceuticals, Inc.
Publication of LT3675816T publication Critical patent/LT3675816T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/US2018/048329T 2017-08-28 2018-08-28 Pailginto atpalaidavimo anestetinės kompozicijos ir jų gamybos būdai LT3675816T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762550983P 2017-08-28 2017-08-28
US201862621730P 2018-01-25 2018-01-25
PCT/US2018/048329 WO2019046293A1 (en) 2017-08-28 2018-08-28 EXTENDED RELEASE ANESTHETIC COMPOSITIONS AND METHODS OF PREPARATION THEREOF

Publications (1)

Publication Number Publication Date
LT3675816T true LT3675816T (lt) 2023-06-26

Family

ID=63668016

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/048329T LT3675816T (lt) 2017-08-28 2018-08-28 Pailginto atpalaidavimo anestetinės kompozicijos ir jų gamybos būdai

Country Status (22)

Country Link
US (2) US11793799B2 (lt)
EP (1) EP3675816B1 (lt)
JP (1) JP7173615B2 (lt)
KR (2) KR20250029892A (lt)
CN (2) CN118105349A (lt)
AU (2) AU2018323436B2 (lt)
CA (1) CA3073734A1 (lt)
CY (1) CY1126137T1 (lt)
DK (1) DK3675816T3 (lt)
ES (1) ES2946919T3 (lt)
FI (1) FI3675816T3 (lt)
HR (1) HRP20230535T1 (lt)
HU (1) HUE062202T2 (lt)
LT (1) LT3675816T (lt)
MX (1) MX393126B (lt)
PL (1) PL3675816T3 (lt)
PT (1) PT3675816T (lt)
RS (1) RS64297B1 (lt)
SI (1) SI3675816T1 (lt)
SM (1) SMT202300163T1 (lt)
TW (1) TWI806894B (lt)
WO (1) WO2019046293A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX393126B (es) * 2017-08-28 2025-03-24 Tlc Biopharmaceuticals Inc Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas
KR102780006B1 (ko) * 2018-03-30 2025-03-10 티엘씨 바이오파머슈티컬즈 인코포레이티드 서방형 마취제 조성물 및 이의 제조 방법
EP3930689A1 (en) 2019-02-26 2022-01-05 TLC Biopharmaceuticals, Inc. Pharmaceutical compositions for use in treating pain
EP3991722A4 (en) * 2019-06-28 2022-10-05 Jiangsu Hengrui Medicine Co., Ltd. LIPID COMPOSITION WITH DELAYED RELEASE AND THEIR PROCESS OF PRODUCTION
CN113116823B (zh) * 2019-12-30 2024-02-20 江苏恒瑞医药股份有限公司 一种脂质体及其制备方法
US20230080811A1 (en) 2020-01-14 2023-03-16 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Long-acting ropivacaine pharmaceutical composition, preparation method therefor and use thereof
CN114668723A (zh) * 2020-12-25 2022-06-28 江苏恒瑞医药股份有限公司 一种含有局部麻醉药的脂质体及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2592791A1 (fr) * 1986-01-14 1987-07-17 Ire Celltarg Sa Composition pharmaceutique, contenant un anesthesique local et/ou un analgesique central encapsule dans des liposomes
US5244678A (en) 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
GB9605915D0 (en) 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
GB9609779D0 (en) 1996-05-10 1996-07-17 Univ Bruxelles Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
EP2198854B1 (en) 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
WO1999049849A1 (en) * 1998-03-31 1999-10-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal bupivacaine compositions and methods of preparation
CA2340118C (en) 1998-08-12 2009-01-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
CN102940878A (zh) * 2006-10-06 2013-02-27 Scil技术股份有限公司 脊柱髓核植入物
JPWO2013146386A1 (ja) * 2012-03-27 2015-12-10 学校法人関西医科大学 局所麻酔薬持続性徐放製剤
TW201427447A (zh) 2012-09-17 2014-07-01 Interdigital Patent Holdings 回載無線電資源及小胞元回載延遲估計自我最佳化
JPWO2014046191A1 (ja) * 2012-09-21 2016-08-18 テルモ株式会社 局所麻酔薬持続徐放性リポソーム製剤
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
WO2018048460A1 (en) * 2014-04-21 2018-03-15 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
MX393126B (es) * 2017-08-28 2025-03-24 Tlc Biopharmaceuticals Inc Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas

Also Published As

Publication number Publication date
SMT202300163T1 (it) 2023-09-06
KR20250029892A (ko) 2025-03-05
KR102800917B1 (ko) 2025-04-24
AU2023266253A1 (en) 2023-12-07
EP3675816B1 (en) 2023-05-17
AU2023266253B2 (en) 2025-01-30
DK3675816T3 (da) 2023-05-30
AU2018323436B2 (en) 2023-12-21
EP3675816A1 (en) 2020-07-08
US11793799B2 (en) 2023-10-24
TW201919598A (zh) 2019-06-01
HUE062202T2 (hu) 2023-10-28
SI3675816T1 (sl) 2023-10-30
WO2019046293A1 (en) 2019-03-07
FI3675816T3 (fi) 2023-06-02
HRP20230535T1 (hr) 2023-09-15
CN111182889A (zh) 2020-05-19
US20240000764A1 (en) 2024-01-04
AU2018323436A1 (en) 2020-03-12
ES2946919T3 (es) 2023-07-27
JP7173615B2 (ja) 2022-11-16
JP2020531540A (ja) 2020-11-05
PL3675816T3 (pl) 2023-09-25
PT3675816T (pt) 2023-05-31
KR20200044902A (ko) 2020-04-29
MX2020002231A (es) 2022-06-14
US20200188374A1 (en) 2020-06-18
RU2020112204A (ru) 2021-10-04
BR112020003743A2 (pt) 2020-09-01
CA3073734A1 (en) 2019-03-07
CY1126137T1 (el) 2023-11-15
CN118105349A (zh) 2024-05-31
RS64297B1 (sr) 2023-07-31
US12280043B2 (en) 2025-04-22
TWI806894B (zh) 2023-07-01
RU2020112204A3 (lt) 2022-02-28
MX393126B (es) 2025-03-24

Similar Documents

Publication Publication Date Title
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
IL287749A (en) Compositions for administering implantable drugs and methods of their use
PT3675816T (pt) Composições anestésicas de libertação prolongada e métodos de preparação das mesmas
PL3298043T3 (pl) Kompozycje polipeptydów SIRP i sposoby zastosowania
ZA201906169B (en) Synthekine compositions and methods of use
IL264613B (en) Hemostatic preparations and methods for their preparation
IL269901B (en) Pharmaceutical compounds and methods of treating cardiovascular diseases
SG10202004071UA (en) Cryoprecipitate compositions and methods of preparation thereof
IL276135A (en) Preparations and methods of use
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
ZA202100780B (en) Bismuth-thiol compositions and methods of use
PL3288379T3 (pl) Kompozycje peptydowe i sposoby stosowania
IL271596A (en) Preparations for administering drugs and methods of using them
GB2568562B (en) Moldable compositions and methods of using thereof
EP3302099A4 (en) Enhanced salt compositions and methods of preparation thereof
PT3503885T (pt) Composição farmacêutica e métodos de utilização
SG11202002351SA (en) Poloxamer compositions and methods of making and using same
IL261794A (en) Preparations and methods for using them
PL3445730T3 (pl) Makrokompozyty i kompozycje z kamienia i szkła oraz sposoby wytwarzania
IL273904A (en) Medicinal resin components and methods for their production and use
IL282671A (en) Therapeutic methods and compositions
GB201919385D0 (en) Compositions and methods of manufacture
IL247645A0 (en) Preparations of seleno-organic compounds and methods of using them
GB201709211D0 (en) A novel composition and methods of preparation thereof